Growing community of inventors

Morristown, NJ, United States of America

Matthew Lamm

Average Co-Inventor Count = 5.40

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Matthew LammLeonardo Resende Allain (2 patents)Matthew LammSantipharp Panmai (2 patents)Matthew LammAditya Tatavarti (2 patents)Matthew LammAndrew M Farrington (2 patents)Matthew LammVarsha Biyyala (2 patents)Matthew LammMarcela Nefliu (2 patents)Matthew LammGerard R Klinzing (2 patents)Matthew LammJie Ren (2 patents)Matthew LammScott Trzaska (1 patent)Matthew LammAlicia V Duran-Capece (1 patent)Matthew LammLeonardo R Allain (1 patent)Matthew LammJie Ren (1 patent)Matthew LammLeonardo R Allain (0 patent)Matthew LammJie Ren (0 patent)Matthew LammMatthew Lamm (3 patents)Leonardo Resende AllainLeonardo Resende Allain (9 patents)Santipharp PanmaiSantipharp Panmai (2 patents)Aditya TatavartiAditya Tatavarti (2 patents)Andrew M FarringtonAndrew M Farrington (2 patents)Varsha BiyyalaVarsha Biyyala (2 patents)Marcela NefliuMarcela Nefliu (2 patents)Gerard R KlinzingGerard R Klinzing (2 patents)Jie RenJie Ren (2 patents)Scott TrzaskaScott Trzaska (10 patents)Alicia V Duran-CapeceAlicia V Duran-Capece (1 patent)Leonardo R AllainLeonardo R Allain (1 patent)Jie RenJie Ren (2 patents)Leonardo R AllainLeonardo R Allain (0 patent)Jie RenJie Ren (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Sharp + Dohme Corp. (2 from 2,405 patents)

2. Aralez Pharmaceuticals Trading Dac (1 from 1 patent)

3. Merck Sharp & Dohme LLC (9 patents)


3 patents:

1. 10842751 - Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine

2. 10603282 - Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine

3. 9604971 - Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/12/2026
Loading…